Pregabalin · Dependence & addiction

Explore medicine guides

Is Pregabalin Addictive? Dependence, Misuse & Getting Help

Understand the clinical differences between tolerance, physical dependence, and addiction, recognize warning signs, and find compassionate UK support.

✓ UK prescribing context✓ Plain-language answers✓ Linked medical sources
Medical information: This page provides general educational information for people in the UK. It is not a substitute for advice from a qualified healthcare professional.

Use this guide to

01UnderstandWhat Pregabalin is used for and how it works.
02CheckDosage, interactions, side effects and warnings.
03PrepareBetter questions for your GP, pharmacist or prescriber.
Pregabalin at a glanceStart with the points most relevant to you
Original productGenuine UK-licensed medicine, supplied through the authorised pharmacy process.
Common usesNerve pain, some seizures and generalised anxiety disorder.
Key cautionDrowsiness and dizziness can affect driving and balance.
Before changing treatmentSpeak with a prescriber before reducing or stopping it.
1
Quick answer: Yes, Pregabalin can cause physical dependence, tolerance, and psychological addiction. Physical dependence develops naturally in many patients taking regular doses and simply means your body will experience withdrawal if you stop abruptly. Psychological addiction involves compulsive use, loss of control, and taking higher doses to experience euphoria. In 2019, the UK reclassified Pregabalin as a Schedule 3 Controlled Drug due to these risks.

Understanding the terms: Dependence, tolerance and addiction

Discussions around prescription medicines often confuse these three distinct clinical concepts:

ConceptClinical DefinitionWhat It Looks Like in Practice
ToleranceA biological phenomenon where the body adapts to the drug, requiring higher doses to achieve the same effectAfter several months on 150mg daily, a patient notices that nerve pain relief or sedation is less potent than when they first started.
Physical DependenceA neuroadaptive state where the body functions normally only in the presence of the drugA patient taking their medicine strictly as prescribed experiences intense sweating, nausea, shaking, and anxiety if they miss doses for 24 hours.
Addiction (Substance Use Disorder)A complex behavioural condition marked by compulsive drug-seeking, craving, and loss of controlTaking extra capsules to cope with emotional distress, seeking early refills, buying medication online, or continuing use despite harm.

Why do people misuse Pregabalin?

At supratherapeutic doses (doses higher than the maximum 600mg daily prescribed limit), Pregabalin produces central nervous system effects that can reinforce misuse:

  • Euphoria and disinhibition: Feelings of intense happiness, floating, relaxation, and reduced social inhibitions.
  • Potentiation of other substances: Users often combine Pregabalin with opioids or alcohol to magnify the euphoric "high," an extremely hazardous practice that dramatically increases fatal overdose risk.
  • Self-medication: Many people who misuse Pregabalin originally began using it to self-medicate untreated trauma, chronic severe pain, severe anxiety, or insomnia.

Warning signs of developing dependence or addiction

It can be difficult to recognize when prescription use is sliding into problematic use. Red flags include:

  • Taking larger doses than your doctor prescribed or taking doses more frequently throughout the day.
  • Feeling intense panic, dread, or distress when your prescription is running low.
  • Contacting your GP surgery for early repeat prescriptions claiming you lost your tablets or are going on sudden holiday.
  • Visiting emergency walk-in centres, out-of-hours GPs, or A&E to obtain extra supplies.
  • Purchasing Pregabalin from friends, illicit street dealers, or unregulated online websites. (Counterfeit street Pregabalin often contains toxic contaminants or synthetic opioids like nitazenes).
  • Hiding your medication, taking extra pills in secret, or lying to your family about your dosage.
  • Finding that Pregabalin is interfering with your work, family life, or personal relationships.

The UK classification as a Controlled Drug

In April 2019, following a comprehensive review by the Advisory Council on the Misuse of Drugs (ACMD), the UK government placed Pregabalin into Schedule 3 of the Misuse of Drugs Regulations 2001 and designated it a Class C Controlled Drug under the Misuse of Drugs Act 1971.

This legal change implemented strict controls:

  • It is illegal to possess Pregabalin without a valid prescription from a registered UK practitioner.
  • Supplying or selling Pregabalin to anyone else carries severe criminal penalties, including up to 14 years in prison.
  • Doctors must write prescriptions with exact word and figure quantities, and prescriptions expire within 28 days.

Where to get compassionate, non-judgemental UK support

If you are worried that you have become dependent on or addicted to Pregabalin, please know that healthcare professionals understand this is a recognized pharmacological challenge. You will not be judged, arrested, or treated with stigma.

Do not stop suddenly: Even if you are desperate to stop, do not abruptly quit Pregabalin on your own. Sudden cessation can cause severe, dangerous withdrawal symptoms or seizures.

Confidential support services available across the UK:

  • Your GP: Schedule a double appointment with your GP. Be completely honest about your doses. Doctors can design a slow, safe, manageable tapering schedule.
  • Frank (Honest Information & Support): Call 0300 123 6600 (free 24/7) or visit talktofrank.com for confidential advice and local service directories.
  • Turning Point: Leading UK social enterprise providing community-based drug and alcohol support services (turning-point.co.uk).
  • We Are With You: Free, confidential support for individuals and families dealing with drug dependence (wearewithyou.org.uk).
  • Change Grow Live (CGL): Community drug and alcohol services operating across England and Wales (changegrowlive.org).

Clinical sources and references

Draft publication status: This page is prepared for a UK audience but has not yet received qualified clinical review.
Author: MediHarbour Editorial Team · Medical reviewer: To be assigned · Review date: Pending · Draft updated: 1 October 2026.
Sources should be checked against current NHS, MHRA, NICE, UK product information and peer-reviewed evidence before publication. Read our editorial policy.